SNI-2011 TO TREAT PATIENTS WITH SJOGREN'S SYNDROME
SNI-2011 TO TREAT PATIENTS WITH SJOGREN'S SYNDROME
批准号:
6121144
负责人:
ALAN W FRIEDMAN
金额:
$1.51万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Sjogren's syndrome is an immunological disorder characterized by dry eyes and dry mouth, which includes diminished or absent secretion of glandular tissue. SNI-2011, a quinuclidine derivative of acetylcholine, is a muscarinic agonist associated with improved glandular ability to increase salivation and lacrima-tion. This study will compare the efficacy of two doses of SNI-2011 (15 mg and 30 mg tid) with placebo on the patients' subjective global evaluation of dryness (mouth, eyes, and overall).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SNI-2011 TO TREAT PATIENTS WITH SJOGREN'S SYNDROME
-
批准号:6281714
-
项目类别:
-
资助金额:$1.36万
-
财政年份:1997
-
负责人:ALAN W FRIEDMAN
-
依托单位:
FUNCTIONAL ROLE OF THE 4F2 ANTIGEN IN T CELL ACTIVATION
-
批准号:3030661
-
项目类别:
-
资助金额:$2.77万
-
财政年份:1992
-
负责人:ALAN W FRIEDMAN
-
依托单位:
FUNCTIONAL ROLE OF THE 4F2 ANTIGEN IN T CELL ACTIVATION
-
批准号:3030659
-
项目类别:
-
资助金额:$3.25万
-
财政年份:1992
-
负责人:ALAN W FRIEDMAN
-
依托单位:
SNI-2011 TO TREAT PATIENTS WITH SJOGREN'S SYNDROME
-
批准号:6309247
-
项目类别:
-
资助金额:$1.51万
-
财政年份:--
-
负责人:ALAN W FRIEDMAN
-
依托单位: